×

To enhance security, Multi-Factor Authentication (MFA) is mandatory for all HL7 users. More information

 

CDA and FHIR Pharmacist Care Plan Implementation Guides

Basics

CDA and FHIR Pharmacist Care Plan Implementation Guides

1232
Ballot - STU to Normative


V3 Documents-Clinical (e.g. CDA)

Implementation Guide

Details

The goal of this project is to develop an electronic care plan with enhanced medication management content based on the templates in the HL7 Implementation Guide for C-CDA Release 2.1: Consolidated CDA for Clinical Notesand FHIR profiles based on the US Core specification. This care plan called 'Pharmacist Care Plan' will serve as a standardized, interoperable document for exchange of consensus-driven prioritized medication-related activities, plans and goals for an individual needing care Pharmacists work in multiple environments (community, hospital, long term care, clinics, etc.) and increasingly participate in patient-centered care teams providing essential clinically oriented patient care services such as medication therapy management, clinical reconciliation (medication, allergies and problems), patient immunization management, disease state monitoring, and therapy adherence programs. The pharmacist works with the patient or care giver to identify manageable medication-related goals of therapy, defines needed interventions and strategies for achieving those goals and monitors outcomes in an iterative process. Consultation with other providers involved in the patient's care are performed as needed. Though the Pharmacist Care Plan is static and represents an instance in time, care for the patient is dynamic and will contains information on the patient, pharmacist and care team's concerns and goals related to medication optimization. The care plan may also contain information related to individual health and social risks that may impact care, planned interventions, expected outcomes, and referrals to other providers or for additional services e.g., nutrition consultation or diagnostic laboratory studies.

The intent of this project is in alignment with the goals set forth in the roadmap - Connecting Health and Care for the Nation A Shared Nationwide Interoperability Roadmap the Office of the National Coordinator for Health Information Technology noted the following:

'Providers should have the tools they need to support care transformation, i.e. using technology that supports the critical role of information sharing. This shift will open up new possibilities for providers in how they engage with patients and interact with other care, support and service team members. For example person-centered planning, which includes individual goals and preferences, is increasingly recognized as an integral tool for supporting person-centered health, individual-provider partnerships, and coordinating care, particularly for individuals with chronic conditions and multiple co-morbidities. In a learning health system, person-centered plans will be seamlessly shared amongst a group of individuals in a way that allows all care, support and service team members to contribute to and maintain the person-centered plan. These interoperable plans will be used to support informed, shared decision-making between providers, patients and the full care support team. Further, the learning health system will require nationwide interoperability to support transparent, integrated cost and quality data, accurate outcome measures, and a continuous cycle of improvement. Information gathered and decisions made during the normal course of care will be transformed, in real-time, into computable data and knowledge that is shared across the learning health system.'

The Pharmacist Care Plan is key to the incorporation of medication-related goals and outcomes into a patient's care profile and planning.

Will adhere to the CDA IG Quality Criteria: http://wiki.hl7.org/index.php?title=CDA_Implementation_Guide_Quality_Criteria

This project scope includes the development of a CDA and FHIR based Pharmacist Care Plan. The FHIR Composition Profiles will be based on the CDA Pharmacist Care Plan sections.


The need is two-fold. The immediate need is support the CMS Medicare Part D Enhanced Medicare Therapy Management (MTM) program that starts on January 1, 2017. This pilot will start in 5 Medicare Part D regions. Applicants in these regions will have the opportunity to leverage pharmacy providers with issues related to medication management and adverse outcomes. The development of the Pharmacist Care Plan would be a mechanism to support the MTM model of enhanced care which includes an individual's goals of therapy and outcomes. Secondly, the movement towards Value based payment (VBP) models has recognized pharmacists as an important part of the well-connected care team that addresses the needs of the patient. In a VBP model, an individual's care is coordinated, managed and supported through documentation of goals and outcomes. Pharmacists have unique training and expertise in the appropriate use of medications and provide a wide array of patient care services in many different practice settings. These services reduce adverse drug events, improve patient safety, and optimize medication use and health outcomes. They are an integral member of the health care team and have unique and frequent access to patients. Pharmacists routinely work with patients to facilitate understanding and compliance with drug regimens, reconcile medications from multiple prescribers, and monitor effectiveness of the treatment. These activities impact the treatment plans of other caregivers. Having a medication-related plan of care shared with those providers and incorporated with care plans developed by other Care Team Member is critical to the overall success of patient's reaching their proposed goals of care. The Pharmacist Care Plan will provide for identification of resources for and obstacles to the patient's compliance with the recommended treatment.



Project Scope Statement (PSS) - Update - Target: November, 2018 Draft Template Content - Target: February 2019 Notice of Intent to Ballot (NIB) - Target: February 2019 Pre-ballot Review - Target: March 2019 Pre-ballot Approval - Target: March 2019 Final Ballot Content Due - Target: March 2019 Ballot Opens for Voting - Target: March to April 2019 Ballot Reconciliation - Target: May to June 2019 Publication - Target: Sept 2019 Normative - Target: TBD


https://confluence.hl7.org/pages/viewpage.action?pageId=31690434

Pharmacy HIT Collaborative, National Council for Prescription Drug Programs

No known dependencies

Standards Development Organizations (SDOs), Payors,Healthcare Institutions (hospitals, long term care, home care, mental health); Other (specify in Misc. Notes below),Pharmaceutical; EHR, PHR

1) Community Care of North Carolina Inc.(CMMI grantee and pharmacist payer). 2) Great Plains Area ( ND, SD, IA, and NE) of the Indian Health Service (federal provider group) 3) QS1 Data Systems (national pharmacy software vendor) 4) PioneerRx Pharmacy Software (national vendor) 5) Rx30 (national pharmacy system) 6) Computer Rx (national pharmacy software vendor) 7) VIP Pharmacy Systems (national pharmacy system) 8) Creative Pharmacist (Clinical Pharmacy Software) 9) Community Pharmacy Enhanced Service Network (CPESN https://www.cpesn.com/ecare-plan/) 10) AssureCare 11) BestRx 12) PDX-NHIN-Rx.com 13) McKesson 14)Pharmetika 15)PrescribeWellness 16)AZOVA 17)DocsInc 18)DocStation 19)FDS 20)Fuse 21)MicroMerchant Systems 22)Omnicell 23)Innovative Pharmacy Solutions 24)Smartlink Health Solutions 25)Speed Script See ONC Interoperability Proving Ground with updated list of Implementers: https://www.healthit.gov/techlab/ipg/node/4/submission/1376

Office of the National Coordinator for Health Information Technology emphasis on integrated, interoperable patient-center care plans and CMS innovation programs to incentivise medication therapy management services.

Clinical Pharmacy Care Plan, Pharmacist Care Plan, Medication Therapy Management Care Plan

N/A

Yes

N/A

Yes

2025 Feb: Sponsorship moved from SD WG to Pharmacy per the following: Notes to reflect https://confluence.hl7.org/spaces/SD/pages/320996417/2025-02-20+Agenda+and+Minutes where SDWG voted to transfer ownership to Pharmacy, and https://confluence.hl7.org/spaces/PHAR/pages/325452650/2025-02-24+Agenda+Meeting+Notes for Pharmacy WG to accept the project. 2023 August: TSC approved STU Extension Request for HL7 FHIR Implementation Guide: Pharmacist Care Plan Document, Release 1 - US Realm for 2 years 2023 March: TSC Approved STU Extension Request for CDA Pharmacist Care Plan for 2 years 2021 June: TSC approved STU Publication Request for HL7 CDA R2 Implementation Guide: Pharmacist Care Plan Document, Release 1 - US Realm 2018 November: Submitted a revised PSS 2016 October: Submitted revised PSS. Ballot strategy: First DSTU. Joint HL7 ballot with NCPDP.
Organization & Realm

Realm Specific - Enter "U.S." or name of HL7 Affiliate below

U.S.
People

Scott Robertson



Pharmacy Work Group

Pharmacy Work Group

Status & Dates

Active

STU - Test Period/Accepting Comments

02/02/2016

09/01/2025

2025 Sept WGM/Ballot

09/01/2025

2025 Sept WGM/Ballot

2019 May Ballot Cycle Info: STU Ballot results: Met basic vote requirements. 0 Negatives to reconcile Document Name: HL7 FHIR Implementation Guide: Pharmacist Care Plan Document, Release 1 - US Realm 2019 May Ballot Cycle Info: STU Ballot results: Met basic vote requirements. 1 Negatives to reconcile Document Name: HL7 CDA R2 Implementation Guide: Pharmacist Care Plan Document, Release 1 - US Realm 2017 Sept Ballot Cycle Info: COMMENT ONLY Ballot results: Did not meet basic vote requirements Document Name: HL7 CDA® R2 Implementation Guide: Pharmacist Care Plan Document, Release 1 - US Realm 2017 Sept Ballot Cycle Info: COMMENT ONLY Ballot results: Did not meet basic vote requirements Document Name: HL7 FHIR® Implementation Guide: Pharmacist Care Plan Document, Release 1 - US Realm
Approvals

08/17/2017


Received


All Received




System Info